共 44 条
[1]
Notice to Applicants for Marketing Authorizations for Proprietary Medicinal Products for Human Use in EC Member States, (1989)
[2]
Drug Approval and Licensing Procedures in Japan 1991, (1992)
[3]
Gallotti, Uggeri, Favilla, Cabrini, de Haen, The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations, Eur J Radiol, 18, pp. S1-S12, (1994)
[4]
Litchfield, Wilcoxon, A simplified method of evaluating dose-effect experiments, J Pharmacol Exp Ther, 96, pp. 99-113, (1947)
[5]
Tallarida, Murray, Manual of pharmacologic calculations with computer programs, (1986)
[6]
Morisetti, Bussi, Bertani, Grandi, Tirone, de Haen, The contribution of osmotic load, volume and time required for administration to the toxicity of X-ray contrast media, Toxicol Lett, (1992)
[7]
Daimon, Kondoh, Yamatsu, Mutagenicity study of iomeprol (II): in vitro cytogenetic study using mammalian cells, Prog Med, 12, pp. 97-104, (1992)
[8]
Iwata, Aoki, Shionoya, Yamatsu, Study on local irritative effect of iomeprol, Prog Med, 12, pp. 115-120, (1992)
[9]
Katsutani, Shionoya, Yamatsu, Antigenicity studies of iomeprol, Prog Med, 12, pp. 108-114, (1992)
[10]
Sovak, New developments in radiographic contrast media, Contrast media: biologic effects and clinical application, (1987)